DUBLIN--(BUSINESS WIRE)--The "Antiplatelet Market: Analysis By Drug Class, By Route of Administration, By Distribution Channel, By Region Size and Trends" report has been added to ...
March 28, 2009 (Orlando, FL) — Two more studies suggesting that a personalized approach to antiplatelet therapy may be appropriate were presented today at the American College of Cardiology 2009 ...
PARIS, FRANCE — Use of morphine in patients undergoing primary PCI for STEMI may delay the onset of action with novel oral antiplatelet agents, potentially exposing patients to risk, a new analysis ...
The application of antiplatelet therapy in dental surgery has become a focal point for clinicians due to the dual needs of maintaining thrombotic protection while minimising perioperative bleeding ...
Washington, D.C. – MAY 1, 2025 – Findings from the Transfusion Requirements in Transcatheter Aortic Valve Implantation (TRITAVI) registry demonstrate that single antiplatelet therapy (SAPT) after ...
Current platelet function assays rely on light transmission aggregometry or proprietary cartridge-based systems, which require specialized expertise, dedicated instruments, and expensive consumables ...
With the aging of the population, use of nonsteroidal anti-inflammatory drugs for musculoskeletal discomfort and other indications has risen. The guideline’s overarching message is that patients who ...
A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor's antiplatelet effects in patients undergoing urgent surgery or experiencing major ...
Please provide your email address to receive an email when new articles are posted on . Dual antiplatelet therapy for 1 month was inferior to 3 months for patients with high bleeding risk after PCI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results